Form D · Other Health Care
Avantor, Inc.
New York, NY · CIK 0001685738
Offering snapshot reported Sep 29, 2016 · SEC filing
- Reported sold
- Yet to sell Indefinite offering
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 29, 2016 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Sep 27, 2016 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-271585
This filing relates to issuances from time to time pursuant to the Avantor, Inc. Equity Incentive Plan at prices determined at the time of grant. For this purpose Options are valued at their exercise price. Does not include grants pursuant to Rule 701.
Source: Form D, filed Sep 29, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Matthew S. Holt | Director, Executive |
| Harris Kealey | Executive |
| Andre Moura | Executive |
| Joseph Walker | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
787 Seventh Avenue 49 Th Floor
New York, NY, 10019
New York, NY, 10019